LINA KARAM to Infliximab
This is a "connection" page, showing publications LINA KARAM has written about Infliximab.
Connection Strength
0.214
-
Disseminated tuberculosis in 2 children with inflammatory bowel disease receiving infliximab. Pediatr Infect Dis J. 2014 Jul; 33(7):779-81.
Score: 0.114
-
Infliximab Can Be Effective in Pediatric Patients with Ulcerative Colitis and Primary Failure of Adalimumab. Ann Clin Lab Sci. 2022 Sep; 52(5):796-801.
Score: 0.050
-
Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North America. J Pediatr Gastroenterol Nutr. 2022 07 01; 75(1):64-69.
Score: 0.049